Bach P, Ti L Hepatitis C and stimulant use disorder: challenges and opportunities Clin Infect Dis PubMed

Jacob J, Ti L, Knight R Will peer-based interventions improve hepatitis C virus treatment uptake among young people who inject drugs? Can J Public Health PubMed

Goodyear T, Ti L, Carrieri P, Small W, Knight R “Everybody living with a chronic disease is entitled to be cured”: Challenges and opportunities in scaling up access to direct-acting antiviral hepatitis C virus treatment among people who inject drugs Int J Drug Policy PubMed

Varghese N, Knight R, Gallagher L, Ti L Treatment of hepatitis C virus infection in marginalized populations Am J Nurs PubMed

Socías ME, Karamouzian M, Parent S, Barletta J, Bird K, Ti L Integrated models of care for people who inject drugs and live with hepatitis C virus: a systematic review Int J Drug Policy PubMed

Ng M, Hayashi K, Voon P, Shulha H, DeBeck K, Milloy MJ, Ti L Characterising the association between positive hepatitis C virus antibody and pain among people who inject drugs Drug Alcohol Rev PubMed

Socías ME, Ti L, Wood E, Nosova E, Hull M, Hayashi K, DeBeck K, Milloy MJ Disparities in uptake of direct-acting antiviral therapy for hepatitis C among people who inject drugs in a Canadian setting Liver Int PubMed

Beaulieu T, Nolan S, Ti L Hepatitis C treatment among incarcerated individuals in Canada and strategies to prevent reinfection in the postrelease period J Epidemiol Community Health PubMed

Knight R, Ti L The successful scale-up of direct-acting antiviral hepatitis C treatments will benefit from concerted investments in implementation science Can J Public Health PubMed